Will a new wave of virtual pain relief through tech-driven solutions make its mark in the IPO market? The recent Hinge Health IPO (HNGE) may offer a glimpse into this. While initial public offerings have seen a steady decline compared to the high volume of 2021, with a strong signal from the recent eToro listing, there is an air of optimism. The company’s unique offering shines a spotlight on its potential impact on the healthcare industry. Hinge Health’s business model centers around musculoskeletal (MSK) care through virtual platforms and AI-powered feedback for exercise plans. Physical therapists will provide guidance, while AI integrates motion capture technology to offer real-time feedback during home exercises. The company is poised to capitalize on an aging global population with a projected 2 billion MSK condition sufferers by 2025. The ability to scale their services using virtual and personalized AI solutions has the potential to revolutionize post-acute care. However, the company’s IPO valuation (with expected shares ranging from $28-$32) is a reflection of market conditions after years of low-interest rate policies. As Hinge Health looks towards its May 22nd, 2025 IPO, it remains to be seen if the company can fully capitalize on this opportunity and deliver long-term value for investors.